Grin Therapeutics

Business Services · New York, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

New York City, New York, United States

Phone Number

(877) 225-0014

Website

www.grintherapeutics.com

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Grin Therapeutics

GRIN Therapeutics is dedicated to the research and development of precision therapeutics for pediatric neurodevelopmental disorders with the goal of bringing hope to patients and caregivers. Late last year, GRIN Therapeutics reported promising topline data from a Phase 1b/2a clinical trial (the Honeycomb Trial, ClinicalTrials.gov NCT identifier: NCT05818943) evaluating radiprodil in GRIN-related neurodevelopmental disorder (GRIN-NDD) in patients with gain-of-function (GoF) variants, leading to the decision to advance to a global Phase 3 trial. The company has an additional ongoing clinical trial to evaluate radiprodil for the potential treatment of tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD) type II. GRIN Therapeutics is an affiliate of Neurvati Neurosciences, a portfolio company of Blackstone Life Sciences.Explore more
Grin Therapeutics's Social MediaPopular SearchesGRIN Therapeutics IncSIC Code 87,873NAICS Code 54,541Show more

Grin Therapeutics Org Chart

PhoneEmail
RE
United States flag for contact location.
Richard Edo

Manager, Clinical Trial

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Grin Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Funding: Get notified immidiatlly once Grin Therapeutics has new funding data

Check if Grin Therapeutics has recently received funding, and reach out quickly before it becomes old news!

Click to see if Grin Therapeutics had a recent Job posting/layoffs

Earning: See what the market has to say on Grin Therapeutics recently announced quarterly report

Check out if Grin Therapeutics is spiking on competitors!

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Grin Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic

Website visits: Recent activity has been detected on your website

Product Launch: Get notified when Grin Therapeutics launches new products

Congratulate Masked Content for being promoted to Masked Content at Grin Therapeutics

Recommended Actions

Find VP level buyers at Grin Therapeutics

Find 2 more new buyers

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Grin Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Grin Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Grin Therapeutics.

Grin Therapeutics financials insights

Gather financial insights about Grin Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2025

Series D

$140M

See All Grin Therapeutics's Financials Insights

Grin Therapeutics Tech Stack

A closer look at the technologies used by Grin Therapeutics

WooCommerce

By

Automattic
WordPress.org

By

Automattic
PHP

By

PHP
Google Tag Manager

By

Google
See more technologies

Most Recent Scoops

Partnership
Project
Grin Therapeutics is sponsoring an interventional clinical trial focused on beeline phase 3 study in GRIN-related neurodevelopmental disorder with Aziende Chimiche Riunite Angelini Francesco S.p.A. The trial began on January 2026 with the expected completion date of July 2028. The trial is currently recruiting participants.
Laboratory Operations, Medical Research, Clinical Operations
Project
Grin Therapeutics is sponsoring an interventional clinical trial focused on radiprodil pharmacokinetics, safety, and tolerability in hepatic impairment. The trial began on March 2026 with the expected completion date of August 2027. The trial is currently in phase one.
Laboratory Operations, Medical Research, Clinical Operations
Executive Move
Gail Farfel, former Chief Executive Officer for ProMis NeuroSciences Inc, has been appointed to the Board of Directors for Grin Therapeutics as a Director.
Executive Moves, Board of Directors
Funding
Grin Therapeutics has secured $140 million in Series D funding. The round included participation from investors Angelini Pharma and Blackstone Life Sciences.
Funding
Project
Research & Development, Product Management, Legal Affairs, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
See more scoops

Top Business Services Companies

Top companies in Canada by revenue

University of Victoria Centre for Aerospace Research
Fluid Life
Access Analytical Laboratories
Michael Smith Health Research BC
Canadian Critical Care Trials Group
View Full List

Top companies in Australia by revenue

PCS Precision
Astralis Instrumentation Consortium
Fisheries Research and Development
Southern Engineering Services
Ektimo
View Full List

Top companies in New Zealand by revenue

Scion
Exsurgo
AP1 Metrology
ZOLL Medical New Zealand
Centre for Advanced Materials Manufacturing and Design
View Full List
See more top companies

Frequently Asked Questions Regarding Grin Therapeutics

What is Grin Therapeutics's official website?
Grin Therapeutics's official website is www.grintherapeutics.com What is Grin Therapeutics's Revenue?
Grin Therapeutics's revenue is <$5 Million What is Grin Therapeutics's SIC code?
Grin Therapeutics's SIC: 87,873 What is Grin Therapeutics's NAICS code?
Grin Therapeutics's NAICS: 54,541 How many employees does Grin Therapeutics have?
Grin Therapeutics has 11-50 employees What industry does Grin Therapeutics belong to?
Grin Therapeutics is in the industry of: Business Services, Research & Development What technology does Grin Therapeutics use?
Some of the popular technologies that Grin Therapeutics uses are: WooCommerce, WordPress.org, PHP, Google Tag Manager How do I contact Grin Therapeutics?
Grin Therapeutics contact info: Phone number: (877) 225-0014 Website: www.grintherapeutics.com What does Grin Therapeutics do?

GRIN Therapeutics is dedicated to the research and development of precision therapeutics for pediatric neurodevelopmental disorders with the goal of bringing hope to patients and caregivers. Late last year, GRIN Therapeutics reported promising topline data from a Phase 1b/2a clinical trial (the Honeycomb Trial, ClinicalTrials.gov NCT identifier: NC... T05818943) evaluating radiprodil in GRIN-related neurodevelopmental disorder (GRIN-NDD) in patients with gain-of-function (GoF) variants, leading to the decision to advance to a global Phase 3 trial. The company has an additional ongoing clinical trial to evaluate radiprodil for the potential treatment of tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD) type II. GRIN Therapeutics is an affiliate of Neurvati Neurosciences, a portfolio company of Blackstone Life Sciences.Read More

 What are Grin Therapeutics social media links?
Grin Therapeutics Linkedin page Grin Therapeutics Twitter page Who invested in Grin Therapeutics?
Grin Therapeutics has 2 investors including Blackstone Life Sciences Associates V( Lux and Angelini Pharma. Is Grin Therapeutics a public company?
Grin Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Grin Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.

Test Drive ZoomInfo's Directories

Browse Directories

Most Searched Industries

Construction Law Firms & Legal Services Business Services Finance Manufacturing Agriculture Software Accounting & Accounting Services Retail Healthcare Energy, Utilities & Waste Treatment Telecommunications Transportation Real Estate
People SearchCompany Search